EP3122333A4 - Zellfreie zusammensetzungen zur zellwiederherstellung sowie verfahren zur herstellung und verwendung davon - Google Patents

Zellfreie zusammensetzungen zur zellwiederherstellung sowie verfahren zur herstellung und verwendung davon Download PDF

Info

Publication number
EP3122333A4
EP3122333A4 EP15768892.0A EP15768892A EP3122333A4 EP 3122333 A4 EP3122333 A4 EP 3122333A4 EP 15768892 A EP15768892 A EP 15768892A EP 3122333 A4 EP3122333 A4 EP 3122333A4
Authority
EP
European Patent Office
Prior art keywords
making
methods
same
cell free
free compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP15768892.0A
Other languages
English (en)
French (fr)
Other versions
EP3122333A1 (de
Inventor
Steve Greco
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Regen Medical Technologies LLC
Original Assignee
Advanced Regen Medical Technologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2014/071667 external-priority patent/WO2015095794A1/en
Application filed by Advanced Regen Medical Technologies LLC filed Critical Advanced Regen Medical Technologies LLC
Publication of EP3122333A1 publication Critical patent/EP3122333A1/de
Publication of EP3122333A4 publication Critical patent/EP3122333A4/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP15768892.0A 2014-03-24 2015-03-24 Zellfreie zusammensetzungen zur zellwiederherstellung sowie verfahren zur herstellung und verwendung davon Pending EP3122333A4 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201461969694P 2014-03-24 2014-03-24
PCT/US2014/071667 WO2015095794A1 (en) 2013-12-20 2014-12-19 Compositions for cellular restoration and methods of making and using same
US14/577,978 US20150174166A1 (en) 2013-12-20 2014-12-19 Compositions for Cellular Restoration and Methods of Making and Using Same
PCT/US2015/022285 WO2015148534A1 (en) 2014-03-24 2015-03-24 Cell free compositions for cellular restoration and methods of making and using same

Publications (2)

Publication Number Publication Date
EP3122333A1 EP3122333A1 (de) 2017-02-01
EP3122333A4 true EP3122333A4 (de) 2017-11-29

Family

ID=54196315

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15768892.0A Pending EP3122333A4 (de) 2014-03-24 2015-03-24 Zellfreie zusammensetzungen zur zellwiederherstellung sowie verfahren zur herstellung und verwendung davon

Country Status (4)

Country Link
EP (1) EP3122333A4 (de)
JP (2) JP6471302B2 (de)
CR (1) CR20160495A (de)
WO (1) WO2015148534A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11286463B2 (en) 2012-03-08 2022-03-29 Advanced ReGen Medical Technologies, LLC Reprogramming of aged adult stem cells
CR20160307A (es) 2013-12-20 2016-11-08 Advanced Regen Medical Tech Llc Composiciones para la restauración de células y métodos para la preparación y utilización de las mismas
US10772911B2 (en) 2013-12-20 2020-09-15 Advanced ReGen Medical Technologies, LLC Cell free compositions for cellular restoration and methods of making and using same
BR112018072198A2 (pt) 2016-04-29 2019-02-12 Advanced ReGen Medical Technologies, LLC composição compreendendo micrornas, método de preparação de uma composição de célula-tronco restaurada, formulação farmacêutica e kit
EP3740576A4 (de) 2018-01-18 2021-10-20 Advanced Regen Medical Technologies, LLC Therapeutische zusammensetzungen und verfahren zur herstellung und verwendung davon

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014028493A2 (en) * 2012-08-13 2014-02-20 Cedars-Sinai Medical Center Exosomes and micro-ribonucleic acids for tissue regeneration

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008501336A (ja) * 2004-06-02 2008-01-24 ソースフアーム・インコーポレイテツド Ｒｎａを含有する微小胞およびそのための方法
CN102802519B (zh) * 2009-06-25 2014-12-31 株式会社日立医疗器械 医用图像摄影装置
EP2363136A1 (de) * 2010-03-02 2011-09-07 Fresenius Medical Care Deutschland GmbH Von Erwachsenenstammzellen abgeleitete Mikrovesikel zur Verwendung bei der therapeutischen Behandlung von Tumorkrankheiten
US20120093885A1 (en) * 2010-10-18 2012-04-19 Northwestern University Therapeutic vesicles
US8747915B1 (en) 2011-09-14 2014-06-10 Vincent C. Giampapa Dietary supplement system for multifunctional anti-aging management and method of use
WO2013066368A1 (en) * 2011-10-03 2013-05-10 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Use of mirna 126 to produce hematopoietic stem cells
US9427450B2 (en) * 2012-01-31 2016-08-30 Xon Cells, Inc. Therapeutic immune modulation by stem cell secreted exosomes
US9295696B2 (en) * 2012-06-08 2016-03-29 University of Pittsburgh—of the Commonwealth System of Higher Education Compositions and methods for restoring or rejuvenating stem/progenitor cell function

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014028493A2 (en) * 2012-08-13 2014-02-20 Cedars-Sinai Medical Center Exosomes and micro-ribonucleic acids for tissue regeneration

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BO YU ET AL: "Exosomes Derived from Mesenchymal Stem Cells", INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 15, no. 3, 7 March 2014 (2014-03-07), pages 4142 - 4157, XP055407121, DOI: 10.3390/ijms15034142 *
DIANA M. IGLESIAS ET AL: "Stem Cell Microvesicles Transfer Cystinosin to Human Cystinotic Cells and Reduce Cystine Accumulation In Vitro", PLOS ONE, vol. 7, no. 8, 13 August 2012 (2012-08-13), pages e42840, XP055408200, DOI: 10.1371/journal.pone.0042840 *
L KORDELAS ET AL: "MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease", LEUKEMIA., 21 January 2014 (2014-01-21), US, XP055406936, ISSN: 0887-6924, DOI: 10.1038/leu.2014.41 *
See also references of WO2015148534A1 *
SERENA RUBINA BAGLIO ET AL: "Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy", FRONTIERS IN PHYSIOLOGY, vol. 3, 1 January 2012 (2012-01-01), XP055406899, DOI: 10.3389/fphys.2012.00359 *

Also Published As

Publication number Publication date
JP2019052182A (ja) 2019-04-04
JP2017510582A (ja) 2017-04-13
WO2015148534A1 (en) 2015-10-01
JP6900358B2 (ja) 2021-07-07
EP3122333A1 (de) 2017-02-01
CR20160495A (es) 2017-05-29
JP6471302B2 (ja) 2019-02-20

Similar Documents

Publication Publication Date Title
HK1244841A1 (zh) 用於選擇性消除所關注細胞的方法和組合物
HK1243333A1 (zh) 用於修飾的t細胞的方法和組合物
EP3223856A4 (de) Verfahren und zusammensetzungen für natürliche killerzellen
EP3129471A4 (de) Verfahren und zusammensetzungen für eine zell-immuntherapie
EP3094720A4 (de) Zusammensetzungen und verfahren zur herstellung von atemwegszellen
EP3224012A4 (de) Verfahren und zusammensetzungen zur betonherstellung
EP3186286A4 (de) Cellulosehaltige zusammensetzungen und verfahren zur herstellung davon
EP3083939A4 (de) Zusammensetzungen zur zellwiederherstellung und verfahren zur herstellung und verwendung davon
EP3116511A4 (de) Zusammensetzungen von selenoorganischen verbindungen und verfahren zur verwendung davon
EP3096757A4 (de) Apilimodzusammensetzungen und verfahren zur verwendung davon
EP3166892A4 (de) Kesselsteinhemmungszusammensetzungen sowie verfahren zur herstellung und verwendung davon
EP3194564A4 (de) Trichodermazusammensetzungen und verfahren zur verwendung
EP3151678A4 (de) Lösliche proteinzusammensetzungen und verfahren zu ihrer herstellung
EP3384038A4 (de) Verfahren und zusammensetzungen zur reprogrammierung von t-zellen
EP3389674A4 (de) Zelluläre glycosaminoglycanzusammensetzung sowie verfahren zur herstellung und verwendung davon
EP3094606A4 (de) Zementzusammensetzungen, strukturen und verfahren zur verwendung
EP3436035A4 (de) Zusammensetzungen und verfahren zur verwendung kleiner mobiler stammzellen
EP3105327A4 (de) Zusammensetzungen und verfahren zur verwendung von mikrorna-inhibitoren
EP3436081A4 (de) Mikrorna-zusammensetzungen und verfahren zur herstellung und verwendung davon
EP3190886A4 (de) Zusammensetzung und verfahren zur verwendung davon
EP3253389A4 (de) Apilimodzusammensetzungen und verfahren zur verwendung davon
EP3217989A4 (de) Zusammensetzungen und verfahren zur stimulierung und erweiterung von t-zellen
EP3110891A4 (de) Zusammensetzungen mit niedrigem gehalt an flüchtigen organischen verbindungen und verfahren zur herstellung und verwendung davon
EP2984164A4 (de) Zusammensetzungen zur zellwiederherstellung und verfahren zur herstellung und verwendung davon
EP3325612A4 (de) Verfahren und zusammensetzungen für stammzelltransplantation

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20161004

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20171026

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 35/12 20150101ALI20171020BHEP

Ipc: A61K 38/00 20060101ALI20171020BHEP

Ipc: A61P 17/00 20060101ALI20171020BHEP

Ipc: A61K 45/06 20060101ALI20171020BHEP

Ipc: A61K 31/7088 20060101ALI20171020BHEP

Ipc: A61K 38/19 20060101ALI20171020BHEP

Ipc: A61K 9/127 20060101AFI20171020BHEP

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1232435

Country of ref document: HK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20181106

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS